SUPALAI PCL-NVDR- BA 1/ TH0371010R13 /
2024-04-25 8:12:06 AM | Chg. 0.000 | Volume | Bid10:55:30 AM | Ask10:55:30 AM | High | Low |
---|---|---|---|---|---|---|
0.474EUR | 0.00% | - Turnover: - |
0.462Bid Size: 25,000 | 0.520Ask Size: 25,000 | 0.474 | 0.474 |
GlobeNewswire
1:09 PM
Phosphorus Brings the Industry’s Only Proactive Cyber-Physical System (CPS) Protection Platform to R...
GlobeNewswire
1:01 PM
HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab
GlobeNewswire
1:00 PM
Gov. Holcomb announces Amazon Web Services plans to invest $11B to create a new data center campus i...
GlobeNewswire
1:00 PM
Purple Biotech's Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract ...
GlobeNewswire
1:00 PM
Nasdaq Reports First Quarter 2024 Results; Strong Execution Delivers Double-Digit Solutions Revenue ...
GlobeNewswire
1:00 PM
PyroGenesis Announces Receipt of Two Separate Milestone Payments Totaling $970,000
GlobeNewswire
1:00 PM
Connectone Bancorp, Inc. Reports First Quarter 2024 Results; Declares Preferred and Increased Common...
GlobeNewswire
1:00 PM
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
GlobeNewswire
1:00 PM
Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quar...
GlobeNewswire
1:00 PM
Wolf Popper LLP Continues its Investigation on Behalf of Investors in Temenos AG
GlobeNewswire
1:00 PM
Wolf Popper LLP Continues its Investigation on Behalf of Investors in Harmony Biosciences Holdings, ...